In Brief: Ostex International
Executive Summary
Ostex International: Robert Glaser joins company as president and chief operating officer. Glaser most recently was with Merck as senior VP-marketing, where he was responsible for all osteoporosis-related products. Seattle-based Ostex discovers and develops diagnostics and therapeutics for skeletal diseases and has agreements with companies including Merck, Wyeth-Ayerst, J&J, Corning Clinical Labs and SmithKline Beecham. Glaser will be replaced at Merck by VP-Marketing Jeremy Allen, who has been with the company since August. Allen also is president of the Merck-affiliated Bone Measurement Institute...